Skip to main content

Disorders of Galactose Metabolism

  • Chapter
Inborn Metabolic Diseases
  • 290 Accesses

Summary

Three inborn errors of galactose metabolism are known, one for each step in the Leloir pathway of galactose conversion to glucose. The first, galactokinase deficiency, is discovered either through newborn screening for hypergalactosemia, or by the chance finding of reducing substance in urine, or by selective urine screening for galactose in infants or older persons examined for nuclear cataracts. In the undiagnosed newborn drinking milk, cataracts develop insidiously within a few weeks as the only clinical manifestation. Galactose-galactitol-glucose diabetes is the only chemical sign. Diagnosis is made by enzyme assay on blood cells or fibroblasts. For treatment, milk and milk products are eliminated from the diet. In transferase deficiency or galactosemia, the second step in the Leloir pathway is blocked. In most developed countries, this defect is discovered through newborn screening, and the more serious clinical symptoms are avoided by prompt treatment. Infants who remain undiagnosed develop symptoms and signs of liver and kidney failure and succumb to sepsis. Survivors develop cataracts and mental impairment. Diagnosis is suggested by the presence of reducing substance in the urine of the fed newborn, and it is made by enzyme assay on blood cells, a liver biopsy specimen, or fibroblasts. Lifelong exclusion of all galactose from the diet is stipulated, but difficult to achieve. Partial transferase deficiency is more frequent than the complete defect. It is treated by a less-than-complete removal of dietary galactose, usually restricted to the first few months of life. The third defect of the Leloir pathway, epimerase deficiency, occurs in both a benign mild form and a severe and crippling form. Both are discovered through newborn screening, using methods sensitive to galactose-1-phosphate and are diagnosed by enzyme assay on blood cells or fibroblasts. Infants with the mild form do not seem to require treatment. The two documented severe cases showed clinical features reminiscent of untreated galactosemia; their dietary treatment proved difficult and unsatisfactory.

“Whenever you consider a galactose disorder, stop milk feeding first and only then seek a diagnosis.”

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gitzelmann R, Hansen RG (1980) Galactose metabolism, hereditary defects and their clinical significance. In: Burman D, Holton JB, Pennock CA (eds) Inherited disorders of carbohydrate metabolism. MTP, Lancaster, pp 61–101

    Chapter  Google Scholar 

  2. Segal S (1989) Disorders of galactose metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 453–480

    Google Scholar 

  3. Gitzelmann R, Steinmann B (1984) Galactosemia: how does long-term treatment change the outcome? Enzyme 32: 37–46

    PubMed  CAS  Google Scholar 

  4. Gitzelmann R (1980) Newborn screening for inherited disorders of galactose metabolism. In: Bickel H, Guthrie R, Hammersen G (eds) Neonatal screening for inborn errors of metabolism. Springer, Berlin Heidelberg New York, pp 67–79

    Chapter  Google Scholar 

  5. Beutler E, Paniker NV, Trinidad F (1971) The assay of red cell galactokinase. Biochem Med 5: 325–332

    Article  CAS  Google Scholar 

  6. Mayes JS, Guthrie R (1968) Detection of heterozygotes for galactokinase deficiency in a human population. Biochem Genet 2: 219–230

    Article  PubMed  CAS  Google Scholar 

  7. Gitzelmann R (1967) Hereditary galactokinase deficiency, a newly recognized cause of juvenile cataracts. Pediatr Res 1: 14–23

    Article  CAS  Google Scholar 

  8. Gitzelmann R (1987) This week’s citation classic. Curr Contents Life Sci 30: 14

    Google Scholar 

  9. Levy HL, Sepe SJ, Walton DS, Shih VE, Hammersen G, Houghton S, Beutler E (1978) Galactose-1-phosphate uridyl transferase deficiency due to Duarte-galactosemia combined variation: clinical and biochemical studies. J Pediatr 92: 390–393

    Article  PubMed  CAS  Google Scholar 

  10. Wharton CH, Berry HK, Bofinger MK (1978) Galactose-l-phosphate accumulation by a Duarte-transferase deficiency double heterozygote. Clin Genet 13: 171–175

    Article  PubMed  CAS  Google Scholar 

  11. Schwarz HP, Zuppinger KA, Zimmerman A, Dauwalder H, Scherz R, Bier DM (1982) Galactose intolerance in individuals with double heterozygosity for Duarte variant and galactosemia. J Pediatr 100: 704–709

    Article  PubMed  CAS  Google Scholar 

  12. Schwarz HP, Schaefer T, Bachmann C (1985) Galactose and galactitol in the urine of children with compound heterozygosity for Duarte variant and classical galactosemia (GtD/gt) after an oral galactose load. Clin Chem 31: 420–422

    PubMed  CAS  Google Scholar 

  13. Jakobs C, Kleijer WJ, Bakker HD, van Gennip AH, Przyrembel H, Niermeijer MF (1988) Dietary restriction of maternal lactose intake does not prevent accumulation of galactitol in the amniotic fluid of fetuses affected with galactosaemia. Prenat Diagn 8: 641–645

    Article  PubMed  CAS  Google Scholar 

  14. Gitzelmann R, Steinmann B (1973) Uridine diphosphate galactose 4-epimerase deficiency II. Clinical follow-up, biochemical studies and family investigation. HeIv Paediatr Acta 28: 497–510

    Google Scholar 

  15. Gitzelmann R (1969) Formation of galactose-1-phosphate from uridine diphosphate galactose in erythrocytes from patients with galactosemia. Pediatr Res 3: 279–286

    Article  PubMed  CAS  Google Scholar 

  16. Gitzelmann R, Hansen RG (1974) Galactose biogenesis and disposal in galactosemics. Biochim Biophys Acta 372: 374–378

    Article  CAS  Google Scholar 

  17. Gitzelmann R, Hansen RG, Steinmann B (1975) Biogenesis of galactose, a possible mechanism of self-intoxication in galactosemia. In: Hommes FA, Van den Berg CJ (eds) Normal and pathological development of energy metabolism. Academic, London, pp 25–37

    Google Scholar 

  18. Donnell GN, Koch R, Fishier K, Ng WG (1980) Clinical aspects of galactosaemia. In: Burman D, Holton JB, Pennock CA (eds) Inherited disorders of carbohydrate metabolism. MTP, Lancaster, pp 103–115

    Chapter  Google Scholar 

  19. Kaufman FR, Donnell GN, Roe TF, Kogut MD (1986) Gonadal function in patients with galactosaemia. J Inherited Metab Dis 9: 140–146

    Article  PubMed  CAS  Google Scholar 

  20. Donnell GN, Bergren WR (1975) The galactosaemias. In: Raine DN (ed) The treatment of inherited metabolic disease. MTP, Lancaster, pp 91–114

    Google Scholar 

  21. Brandt NJ (1980) How long should galactosaemia be treated? In: Burman D, Holton JB, Pennock CA (eds) Inherited disorders of carbohydrate metabolism. MTP, Lancaster, pp 117–124

    Chapter  Google Scholar 

  22. Koch R, Acosta P, Ragsdale N, Donnell GN (1963) Nutrition in the treatment of galactosemia. J Am Diet Assoc 43: 216–222

    PubMed  CAS  Google Scholar 

  23. Koch R, Acosta P, Donnell G, Lieberman E (1965) Nutritional therapy of galactosemia. Management success depends on rigid exclusion of all galactose-containing foods. Clin Pediatr 4: 571–576

    Google Scholar 

  24. Clothier CM, Davidson DC (1983) Galactosaemia workshop. Hum Nutr Appl Nutr 37A: 483–490

    PubMed  CAS  Google Scholar 

  25. Gitzelmann R, Auricchio S (1965) The handling of soya alpha-galactosides by a normal and a galactosemic child. Pediatrics 36: 231–235

    PubMed  CAS  Google Scholar 

  26. Steffen C (1975) Enzymatische Bestimmungsmethoden zur Erfassung der Gärungsvorgänge in der milchwirtschaftlichen Technologie. Lebensm Wiss Technol 8: 1–6

    CAS  Google Scholar 

  27. Kaufman FR, Ng WG, Xu YK, Guidici T, Kaleita TA, Donnell GN (1989) Treatment of patients (PTS) with classical galactosemia ( G) with oral uridine. Pediatr Res 25: 142A

    Google Scholar 

  28. Rogers S, Bovee BW, Segal S (1989) Effect of uridine on hepatic galactose-1-phosphate uridyltransferase. Enzyme 42: 53–60

    PubMed  CAS  Google Scholar 

  29. Sardharwalla IB, Komrower GM, Schwarz V (1980) Pregnancy in classical galactosaemia. In: Burman D, Holton JB, Pennock CA (eds) Inherited disorders of carbohydrate metabolism. MTP, Lancaster, pp 125–132

    Chapter  Google Scholar 

  30. Gitzelmann R (1969) Estimation of galactose-1-phosphate in erythrocytes: a rapid and simple enzymatic method. Clin Chim Acta 26: 313–316

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gitzelmann, R. (1990). Disorders of Galactose Metabolism. In: Fernandes, J., Saudubray, JM., Tada, K. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02613-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-02613-7_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-02615-1

  • Online ISBN: 978-3-662-02613-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics